rEVO Biologics' IPO

rEVO Biologics raised a round of funding on September 06, 2005. Investors include Public.

rEVO Biologics, fka GTC Biotherapeutics, is a rare disease company focused on developing and delivering therapeutics that are more cost effective to produce than traditional recombinant therapies. Thr…

Articles about rEVO Biologics' IPO: